Skip to main content

Detoxification from Opiates and Benzodiazepines

  • Chapter
Pain Management and Palliative Care

Abstract

Drug abuse is in epidemic proportions throughout the United States, with an estimated total economic cost of nearly 100 billion dollars: The illegal use of opiates, i.e., heroin and prescription drugs, is on the rise in the United States. In recent years, opiate-induced deaths have increased in particular because of more potent drugs and accessibility. Emergency rooms have reported an increase of 35 % in opiate-related morbidities and mortalities compared to 1995. The continuing rise in abuse of opiates has placed greater emphasis on treatment modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AAOD:

Anesthesia-assisted opiate detoxification

CES:

Cranial electrostimulation

DEA:

Drug enforcement agency

HBV:

Hepatitis B

HCV:

Hepatitis C

HIV:

Human immunodeficiency virus

NSAIDs:

Non-steroidal anti-inflammatory drugs

UROD:

Ultra rapid opiate detoxification

References

  1. http://www.nida.nih.gov/Infofax/costs.html

  2. http://www.nida.nih.gov/Infofax/heroin.html

  3. Kaye AD, Gevirtz C, Bosscher HA, et al. Ultrarapid opiate detoxification: a review. Can J Anaesth. 2003;50:1–9.

    Article  Google Scholar 

  4. Krabbe PF, Koning JPF, Heinen N, et al. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences. Addict Biol. 2003;8:351–8.

    Article  CAS  PubMed  Google Scholar 

  5. McCabe S. Rapid detox: understanding new treatment approaches for the addicted patient. Perspect Psychiatr Care. 2000;36:113–9.

    Article  CAS  PubMed  Google Scholar 

  6. Gevirtz C, Frost E. Ultra rapid opiate detoxification. Curr Concepts Curr Opin Clin Exp Res. 2000;2:151–68.

    Google Scholar 

  7. Gerra G, Zaimovic A, Giusti F, et al. Lofexidine versus clonidine in rapid opiate detoxification. J Subst Abuse Treat. 2001;21:11–7.

    Article  CAS  PubMed  Google Scholar 

  8. Diaz A, Pazos A, Florez J, et al. Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonism. Neuroscience. 2002;112:345–53.

    Article  CAS  PubMed  Google Scholar 

  9. Pilling S, Strang J, Gerada C. Psychosocial interventions and opioid detoxification for drug misuse: summary of NICE guidance. BMJ. 2007;335:203–5.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Madden ME, Shapiro SL. The methadone epidemic: methadone-related deaths on the rise in Vermont. Am J Forensic Med Pathol. 2011;32:131–5. doi:10.1097/PAF.0b013e3181e8af3d.

    Article  PubMed  Google Scholar 

  11. Charney DS, Heninger GR, Kleber HD. The combined use of clonidine and naltrexone as a rapid, safe and effective treatment of abrupt withdrawal from methadone. Am J Psychiatry. 1986;143:831–7.

    Article  CAS  PubMed  Google Scholar 

  12. Jasinski DR. Tolerance and dependence to opiates. Acta Anaesthesiol Scand. 1997;41:184–6.

    Article  CAS  PubMed  Google Scholar 

  13. Kleber HD, Topazian M, Gaspari J, et al. Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. Am J Drug Alcohol Abuse. 1987;13:4–17.

    Article  Google Scholar 

  14. O’Brien CP, McLellan AT. Myths about the treatment of addiction. Lancet. 1996;347:237–40.

    Article  PubMed  Google Scholar 

  15. Broers B, Giner F, Dumont P, Mino A. Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 months. Drug Alcohol Depend. 2000;58:85–92.

    Article  CAS  PubMed  Google Scholar 

  16. Fudala PJ, Jaffe JH, Dax EM, Johnson RE. Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther. 1990;47:525–34.

    Article  CAS  PubMed  Google Scholar 

  17. Alling FA, Johnson BD, Elmoghazy E. Cranial electrostimulation (CES) use in the detoxification of opiate-dependent patients. J Subst Abuse Treat. 1990;7:173–80.

    Article  CAS  PubMed  Google Scholar 

  18. Gevirtz C. Anesthesia assisted opiate detoxification. Int Anesthesiol Clin. 2003;41:79–93.

    Article  PubMed  Google Scholar 

  19. Bell J, Kimber J, Lintzeris N. Guidelines for rapid detoxification from opioids. NSW Health, circular no. 2001/17, file no. 00/1287, issued on 23 February 2001.

    Google Scholar 

  20. Kaye AD, Gevirtz C, Bosscher HA, Duke JB, Frost EA, Richards TA, et al. Ultrarapid opiate detoxification: a review. Can J Anaesth. 2003;50:663–71.

    Article  PubMed  Google Scholar 

  21. Bochud Tornay C, Favrest B, Monnat M, Daeppen JB, Schnyder C, Bertschy G, et al. Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation. Drug Alcohol Depend. 2003;69:283–8.

    Article  CAS  PubMed  Google Scholar 

  22. Hensel M, Kox WJ. Safety, efficacy and long term results of a modified version of rapid opiate detoxification under general anesthesia: a prospective study in methadone, heroin, codeine and morphine addicts. Acta Anaesthesiol Scand. 2000;44:326–33.

    Article  CAS  PubMed  Google Scholar 

  23. Poshychinda V. Thailand: treatment at the Tam Kraborg Temple. In: Edwards G, Arif A, editors. Drug problems in the sociocultural context: a basis for policies and program planning. Geneva: World Health Organization; 1980. p. 121–5.

    Google Scholar 

  24. Kienbaum P, Scherbaum N, Thurauf N, Michel M, Gastpar M, Peters J. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine metabolic and cardiovascular patterns. Crit Care Med. 2000;28:969–76.

    Article  CAS  PubMed  Google Scholar 

  25. Christie MJ, Williams JT, Osborne PB, Bellchambers CE. Where is the locus in opioid withdrawal? Trends Pharmacol Sci. 1997;18:134–40.

    Article  CAS  PubMed  Google Scholar 

  26. Keinbaum P, Thurauf N, Michel M, et al. Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after μ-opioid receptor blockade in opioid addicted patients. Anesthesiology. 1998;88:1154–61.

    Article  Google Scholar 

  27. Langer SZ. Presynaptic regulation of release of catecholamines. Pharmacol Rev. 1981;32:337–62.

    Google Scholar 

  28. Gold MS, Redmond Jr DE, Kleber HD. Noradrenergic hyperactivity in opiate withdrawal supported clonidine reversal of opiate withdrawal. Am J Psychiatry. 1979;136:100–2.

    Article  CAS  PubMed  Google Scholar 

  29. Gold MS. Opiate addiction and locus ceruleus. The clinical utility of clonidine, naltrexone, methadone and buprenorphine. Psychiatr Clin North Am. 1993;16:61–73.

    CAS  PubMed  Google Scholar 

  30. Croissant B, Grosshans M, Diehl A, Mann K. Oxcarbazepine in rapid benzodiazepine detoxification. Am J Drug Alcohol Abuse. 2008;34(5):534–40. doi:10.1080/00952990802149021.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alan David Kaye M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gevirtz, C., Kaye, A.D. (2015). Detoxification from Opiates and Benzodiazepines. In: Sackheim, K. (eds) Pain Management and Palliative Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2462-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2462-2_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2461-5

  • Online ISBN: 978-1-4939-2462-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics